Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2016 Q2- Text added to 2016 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. freshman Avg
|
New words:
anniversary, annum, apply, Astra, AstraZeneca, began, begun, bore, CancerWe, clause, clear, clearance, colorectal, commonly, conformity, criteria, critical, declared, difficult, DOD, durvalamab, earlier, eligible, employed, excellent, force, forward, FR, fractional, half, identical, independent, inherent, inventor, Keith, Knutson, left, Loiacono, lyophilized, move, national, notification, NRS, observable, opinion, orderly, original, percent, platinum, precluded, quoted, radiation, ratio, real, reduction, reformulated, relationship, remit, resale, resistant, restated, risk, Secretary, simplification, specific, submission, supply, supplying, symbol, ticker, Treasurer, Trialson, Tuesday, unadjusted, unmet, Unrecognized, unresponsive, unrestricted, vetting, viable, women, Zeneca
Valuein 2016 Q2 filing- Value in 2016 Q3 filing
Original filings
Filing view